Crystalplex develops and commercializes innovative fluorescent markers for use in basic life science research, pharmaceutical research, diagnostics and histology. The technology is based on proprietary composition-tunable nanocrystals (quantum dots).
Quantum Materials Corporation (QMC) is now commercializing a low cost quantum dot technology of a superior quality and characteristics. This revolutionary new quantum dot production technique, developed by Dr. Michael S. Wong and colleagues of William Marsh Rice University, Houston, TX., has been acquired under an exclusive, world-wide license. Our new synthesis method is mass producible using continuous flow technology processes developed in conjunction with Access2Flow microreactor technology. QMC's research and development group was instrumental in developing the new scaling-up process.